|
Volumn 98, Issue 9, 2001, Pages 5181-5186
|
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER SURVIVAL;
CELLULAR IMMUNITY;
CLINICAL FEATURE;
CONTROLLED STUDY;
EFFECTOR CELL;
FEMALE;
IMMUNE RESPONSE;
MOUSE;
MYELOMA;
NONHUMAN;
PRIORITY JOURNAL;
QUALITY OF LIFE;
T LYMPHOCYTE;
TUMOR REGRESSION;
ANIMALS;
BLOTTING, WESTERN;
DISEASE MODELS, ANIMAL;
DISEASE PROGRESSION;
ERYTHROPOIETIN;
FEMALE;
HEMOGLOBINS;
HUMANS;
IMMUNOGLOBULIN LAMBDA-CHAINS;
IMMUNOPHENOTYPING;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
MICE, INBRED STRAINS;
MULTIPLE MYELOMA;
REMISSION INDUCTION;
SURVIVAL RATE;
T-LYMPHOCYTES;
ANIMALIA;
MURINAE;
|
EID: 0035942272
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.081275298 Document Type: Article |
Times cited : (161)
|
References (30)
|